Abstract
Updated Efficacy of Eltanexor Monotherapy in Patients with Higher Risk Hypomethylating Myelodysplastic Syndrome Primary Refractory to Hypomethylating Agents
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have